The personal cancer screening behaviours of nurses and midwives by Nicholls, R et al.
"This is the peer reviewed version of the following article: [Journal of Advanced Nursing, 2017, 73 
(6), pp. 1403 - 1420], which has been published in final form at 
[http://dx.doi.org/10.1111/jan.13221]. This article may be used for non-commercial purposes in 








THE PERSONAL CANCER SCREENING BEHAVIOURS OF NURSES AND MIDWIVES’   
Rachel NICHOLLS, Research Fellow, Faculty of Health, University of Technology Sydney, New South 
Wales, Australia, PhD, MPH, BA 
 
Lin PERRY, Professor of Nursing Research & Practice Development, Faculty of Health, University of 
Technology Sydney, Australia, PhD, MSc, RN. 
 
Robyn GALLAGHER, Professor of Nursing, Charles Perkins Centre, Sydney Nursing School, University 
of Sydney, Sydney, New South Wales, PhD, MN, RN. 
 
Christine DUFFIELD, Professor of Nursing and Health Services Management and Director, Centre for 
Health Services Management, Faculty of Health, University of Technology Sydney, New South Wales 
and Edith Cowan University, Perth, Western Australia, PhD, MHP, RN. 
 
David SIBBRITT, Professor of Epidemiology, Faculty of Health, University of Technology Sydney, New 
South Wales, PhD, MMedStat, BMath. 
 
Xiaoyue XU, Research Fellow, Faculty of Health and Medicine, University of Newcastle, Australia, 
PhD Candidate, MPH, MSc, BN. 
 
Corresponding author contact details: Rachel Nicholls, Faculty of Health,University of Technology 






Conflict of interest: No conflict of interest was declared by the authors in relation to the study itself. 
Note that Robyn Gallagher is a JAN editor but, in line with usual practice, this paper was subjected to 
double blind peer review and was edited by another editor.  
Funding: Australian Research Council (ARC) grant number: LP130100694, New South Wales Nurses 
and Midwives Association (NSWNMA) 
ABSTRACT 
Aim:   
To identify the personal cancer screening behaviours of nurses and midwives in New South Wales, 
Australia, and identify factors predictive of cancer screening uptake. 
Background:  
The nursing workforce may have a higher risk for some cancers and is ageing.  In Australia, more 
than 40 percent are over 50 years - an age where cancer incidence rises rapidly, but when screening 
may reduce cancer mortality. Nurses and midwives are important health role models for the 
population, but their engagement in cancer screening is unknown.  
Design:  
A cross-sectional survey conducted in 2014-15. 
Methods:   
Data were obtained from the ‘Fit for the Future’ study on 5,041 working nurses and midwives in 
New South Wales, Australia, and analyses were conducted on subsets of age-eligible respondents. 
Demographic, geographical and occupational data were analysed in relation to population-based 
screening for breast, cervical, and bowel cancers and opportunistic screening for prostate and skin 
cancer screening participation, in line with Australian recommendations.  





Nurses’ and midwives’ recent screening rates were higher than the Australian general population 
across relevant age groups. Compared with full-time nurses and midwives, part-time/casual/pool 
workers were significantly more likely to undertake cervical, breast and bowel screening. Compared 
to those working office hours, shift workers were significantly less likely to undertake breast and 
bowel screening, but more likely to undertake skin screening.  
Conclusions:  
Disparities in reported screening prevalence and factors predictive of screening uptake indicate 
opportunities for targeted strategies to inform and/or promote workforce engagement with 
screening programs and protect the health of this ageing workforce. 
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Why is this research needed? 
 Nurses and midwives may have a higher risk of certain cancers compared with the general 
population, which is attributed to occupational features.  The workforce is also ageing and 
with age comes an increased risk for cancer.   
 Little is known about nurses and midwives’ cancer screening behaviours despite the role of 
screening in reducing cancer morbidity and mortality. 
 By identifying workforce cancer screening behaviours and factors predictive of screening 
uptake, this study provides information to support development of targeted strategies to 
promote nurses and midwives’ engagement in routine screening (where appropriate) 
What are the key findings? 
 Nurses’ and midwives’ recent screening rates were higher than the Australian general 
population across relevant age groups. However, although higher than the general 
population, nurses and midwives have low participation in bowel and skin cancer screening. 
 Over half of male nurses had recently been screened for prostate cancer, despite a lack of 
support for prostate specific antigen (PSA) testing by leading cancer control agencies at the 
time of screening (new guidelines emphasise informed consent and biennial screening 50-69 
years if appropriate). 
 Compared with full-time nurses and midwives, part-time/casual/pool workers were 
significantly more likely to undertake cervical, breast and bowel screening.  Shift workers 
were significantly less likely to undertake breast cancer and bowel screening than those 
working office hours. 
 





 Given the impact of cancer and other non-communicable diseases on health and 
productivity, and the global shortage of nurses, it is time to identify and support preventive 
health behaviours of nurses and midwives.  
 Targeted strategies in the workplace should be developed that focus on informing and/or 
enabling full-time and shift workers to engage in routine cancer screening. 
 Targeted workplace-accessible screening programs should be developed that focus on 








Nurses may have a higher risk for certain cancers compared with the general population (Shen et al. 
2013, Kjaer and Hansen 2009), attributed to long-term shift and night work and occupational 
exposure to carcinogens (Schernhammer et al. 2001, Schernhammer et al. 2003, Ratner et al. 2010). 
Furthermore, some specific occupational characteristics have been correlated with unhealthy 
lifestyle behaviours in nurses and midwives that increase the risk of cancers, including harmful 
drinking and long working hours (Schluter et al. 2012) and cigarette smoking and rotating night shift 
work (Schernhammer et al. 2013). The nursing and midwifery workforce is also ageing: the most 
important risk factor for cancer overall (AIHW 2012). Increased cancer risks provide impetus not just 
to improve workplace conditions but also to support workforce cancer screening as these actions are 
likely to reduce cancer incidence and mortality. The adherence of Australian nurses and midwives to 
cancer screening recommendations is unknown, but by determining participation, effort may be 
directed toward informing, promoting and enabling uptake where appropriate. 
Background  
Multiple cohort and case-control studies have found an association between working as a nurse and 
an increased risk of certain cancers, including breast, ovarian, prostate, melanoma, and bowel 
cancer (Peipins et al. 1997, Gu et al. 2015, Kjaer and Hansen 2009, Lie et al. 2007, Lie et al. 2006, 
Gunnarsdóttir and Rafnsson 1995, Sankila et al. 1990, Rix and Lynge 1996, Morton 1995, 
Schernhammer et al. 2001, Schernhammer et al. 2003, Conlon et al. 2007, Hansen and Stevens 2012, 
Jia et al  . 2013, Lie et al. 2011). For breast cancers in particular, this increased risk is primarily 
attributed to long durations of night shift work, the resulting circadian rhythm disruption, and the 
reduced secretion of the hormone melatonin that has tumour-suppressing properties (Haus and 
Smolensky 2013).  
The circadian rhythm disruption in night shift workers is also likely to make the skin more susceptible 





skin cancers (Gutierrez et al. 2016). However, as with all cancers investigated in nurses the evidence 
is inconclusive and further studies are required. Increased melanoma risk was reported in studies 
with large nurse samples (Lie et al. 2007, Kjaer and Hansen 2009), and a decreased risk for skin 
cancers was reported in nurses working night shifts for 10 or more years, compared with those 
never working shifts (Schernhammer et al. 2011). Rotating night shift nurses were also found to have 
a decreased risk for cervical cancer compared to the general population (Shen et al. 2013).    
These data can be placed in context with overall cancer incidence in Australia. In this country, the 
most commonly diagnosed cancer (excluding non-melanoma skin cancer) is prostate, followed by 
breast, bowel, melanoma and lung cancers (AIHW 2014). Worldwide, Australia has one of the 
highest incidence rates for these cancers, most notably melanoma, of which the incidence is two to 
three times higher than any other country except New Zealand (Parkin et al. 2001, Erdmann et al. 
2003).    
In 2010, the International Agency for Research on Cancer (IARC) assessed all available evidence and 
classified shift work involving circadian rhythm disruption as ‘probably carcinogenic’ to humans 
(IARC 2010). The IARC also identified some biological and chemical agents that nurses may be 
exposed to in their working lives as ‘carcinogenic’ or ‘probably carcinogenic’, including ionizing 
radiation, anaesthetic waste gases, antineoplastic drugs, ethylene oxide and formaldehyde.  
Exposure to these hazards has been linked to elevated risks for numerous types of cancers in nurses 
(particularly breast and leukaemia), although the majority of studies were registry studies with 
limited data on confounding factors (Lie and Kjaerheim 2003).   
Other occupational features of nursing such as the working hours, work practices and conditions 
have been linked to unhealthy behaviours in nurses and midwives that pose risks for development of 
cancers, such as a poor diet, low physical activity, smoking and harmful alcohol consumption (Han et 
al. 2011, Wong et al. 2010, Tucker et al. 2010, Schernhammer et al. 2013, Sarna et al. 2010, Schluter 





rates exceeding that of the general population.  Obesity for example - a risk factor in bowel, breast 
and other cancers - was reported as 28% in a study of nurses and midwives, compared with general 
population rates, which were: 17.5% (Australia), 26.5% (New Zealand) and 25% (United Kingdom) 
(Bogossian et al. 2012).  
Internationally, observational study samples tend to report nurses with higher smoking and harmful 
drinking rates than the public, although large population-based studies have more positive findings. 
The Australian Health Survey reported the proportion of nurses who smoked (14%) or drank alcohol 
excessively (11%) as less than other workers in Australia, at 19% and 23% respectively (ABS 2013). 
Danish nurse samples of over 43,000 and 92,140 demonstrated significantly decreased risks for 
alcohol and tobacco-related cancers (Lie et al. 2007, Kjaer and Hansen 2009). Such studies indicate – 
at least in regard to alcohol and smoking – relatively healthier lifestyle habits amongst some nurse 
populations.  
The ageing of the nursing and midwifery workforce is also an important consideration given the risk 
for cancer increases with age. In the past 20 years, the workforce has been ageing faster than the 
general population and, similar to other ‘Western’ countries, nearly 40 percent of nurses in Australia 
are now aged 50 years and older, an age group in which the incidence of cancers increases rapidly 
(AIHW 2013a). While increased life expectancy may offer nurses and midwives the opportunity to 
stay longer in the workforce, an increasing burden of cancer and other non-communicable diseases 
will limit the ability of older workers to meet work demands and may be a factor in early retirement 
and premature loss of experienced staff (Wong et al. 2010).  
Given these identified cancer risks for nurses and midwives, prevention and early diagnosis of cancer 
can be considered a priority. This will not only protect employees’ health but also ensure nurses and 
midwives are available and able to care for the health of the public, including role modelling healthy 





breast, cervical and bowel cancer (and incidence of bowel and cervical cancer) through organised 
population-based screening programs (IARC 2015).  
Australia currently has three national population-based screening programs: the breast, bowel and 
cervical programs. These programs invite defined asymptomatic populations to undergo regular 
screening tests, with the aim of detecting and treating pre-cancerous (cervical and bowel) or early 
cancerous lesions (breast) before they progress. Breast screening mammography is offered to 
women aged 50-69 years biennially in Australia, and has just been expanded to include the 70-74 
years’ age group (BreastScreen Australia 2016). The National Bowel Cancer Screening Program 
(NBCSP) sends immunochemical faecal occult blood test (FOBT) kits to men and women aged 
between 50 and 74 every 5 years, but is currently being expanded to offer biennial screening (NBCSP 
2016). Routine cervical screening is offered biennially to Australian women aged 18-69 years with a 
normal history, but change is also underway in this program with the advent of the Human 
Papilloma Virus (HPV) vaccine and high risk HPV testing (NCSP 2016).    
Prostate and skin cancer screening are conducted opportunistically in Australia and are not a part of 
an organised population screening program (NHMRC 2013 and ACN MGRWP 2008). Regular skin 
checks by a clinician are not recommended for asymptomatic people at average risk of skin cancer, 
because non-melanoma skin cancer has low mortality; general practitioner examination is not 
sufficiently accurate and a population screening program cannot be justified on economic grounds 
(Helfand et al. 2001, Cancer Council Australia 2014).  However, current skin screening 
recommendations encourage people to regularly check their skin for new or changed skin lesions, 
and to undergo opportunistic skin examination by a medical practitioner if concerned (Cancer 
Council Australia, 2014).    
Both skin clinical and self-examination are likely to increase the chances of detecting thinner 
melanoma lesions which are less likely to have metastasised (Carli et al. 2003, Aitken et al. 2010). 





on melanoma mortality, and only one case control study supports a link between skin self-
examination and reduced melanoma mortality (Berwick et al. 1996).  Nationwide clinical skin cancer 
screening in Germany (introduced in 2008) has not demonstrated a decline in mortality (Katalinic et 
al. 2015).  
Population-based prostate-specific antigen (PSA) screening for men at average risk is not 
recommended by leading Australian cancer control bodies because evidence that PSA screening 
reduces mortality is inconsistent, the test is unreliable and there are concerns about potential harms 
associated with over-diagnosis (NHMRC, 2013).  If prostate cancer is diagnosed, it may not be life-
threatening and yet harms associated with treatment are substantial, including sexual dysfunction 
and compromised urinary and bowel function (NHMRC 2013, Cancer Council Australia 2010).  
Current Australian recommendations are that men at average risk, aged 50-69 years, who have been 
informed of the benefits and harms of screening and decide to undergo prostate screening, have a 
PSA blood test every 2 years (PCFA and Cancer Council Australia, 2015). Informed consent is 
emphasised: the positive and negative aspects of PSA testing should be discussed with a General 
Practitioner before making a decision about whether to proceed (PCFA and Cancer Council Australia, 
2016).    
In summary, in common with all appropriately aged Australians, ostensibly healthy nurses and 
midwives in Australia are actively invited to take part in three national cancer screening programs 
and skin self-examination and prostate screening are recommended (with provisos). Identification of 
participation in screening of this ageing workforce will provide information to support development 
of targeted strategies to promote their informed consent and/or engagement in recommended 
screening. Screening may protect their health, contribute to the retention of experienced workers 







To identify the personal cancer screening behaviours of nurses and midwives in New South Wales, 
Australia and identify factors predictive of screening uptake. 
 Design  
A cross-sectional survey conducted in 2014-15. 
Data collection 
Sample 
This sub-study used data collected for the ‘Fit for the Future’ study, that included a cross-sectional 
web-based survey with 5,041 useable responses from nurses and midwives working in New South 
Wales (NSW), Australia. Recruitment was via email to the membership of the New South Wales 
Nurses and Midwives Association (NSWNMA) - a professional association and trade union - and 
through publicity material in trade journals, electronic staff newsletters, professional networks and 
social media. Three reminder emails were sent to NSWNMA members. The survey was launched in 
June 2014 and open until February 2015.   
 
Participants  
Approximately 88,319 Registered and Enrolled nurses and 9,524 midwives were eligible to join the 
‘Fit for the Future’ study; Assistants in Nursing (unlicensed health workers), whose numbers in NSW 
are unknown, were not excluded. The online nature of the survey and the diverse recruitment 
techniques mean the numbers who received an invitation to participate are not known. Of the total 
5,446 responses, 405 (7.4%) were excluded due to missing data or because respondents were non-
practicing, leaving 5,041 respondents. The respondent profile was similar to that of the Australian 






Sub-study participants were those who completed the relevant screening questions and met the 
following age criteria in accordance with Australian cancer screening guidelines/ recommendations: 
(1) Cervical screening: female nurses and midwives aged 18-69 years (N= 3,710), to identify 
those who had ever undergone screening/screening within the last two years (‘Pap’ test); 
(2) Breast screening: female nurses and midwives aged 50-69 years (N= 2,162), to identify 
those who had ever undergone screening /screening within the last two years 
(mammography); 
(3) Bowel screening: male and female nurses and midwives aged 50-74 years (N= 2,235), to 
identify those who had ever undergone screening / screening within the last two years 
(FOBT, but may also include sigmoidoscopy (FS) and/or colonoscopy);  
(4) Skin cancer screening: adult male and female nurses and midwives of any age (N= 4,260), 
to identify those who had ever undergone screening (self-examination and/or clinical skin 
examination); and 
(5) Prostate screening: male nurses aged 50-70 years (N= 169), to identify any screening (PSA 
with or without DRE). 
Ethics approval 
The study was approved by the relevant hospital and university Human Research Ethics Committees.  
 
Validity, reliability and rigour 
Questionnaire items were selected and/or adapted from other studies, with some additional items 
developed by the authors based on the literature review, consultation and preliminary testing in two 
acute hospitals in Sydney (Perry et al. 2015).  The screening behaviour questions were drawn from 
the Australian Longitudinal Study on Women’s Health a long-running, extensively validated 






Full details of the questionnaire are reported elsewhere (Perry 2016), but briefly, the Fit for the 
Future questionnaire comprised: (1) demographic characteristics, (2) workforce variables and (3) 
general health, health behaviours and well-being.  
Demographic and occupational factors: 
Demographic and employment variables included age, gender, work roles, shifts and work contract. 
Participants’ current primary work roles were classified as: (1) Assistants in Nursing (AINs); (2) 
foundational nurse (front-line clinical staff); (3) domain specific (educators/ managers/ researchers); 
(4) advanced practice nurses and midwives (with a scope of practice beyond that allowed by 
ordinary registration). We collapsed the separate categorisation identified by Gardner et al. (2016) 
to collate Nurse/ Midwife Practitioners with Advanced Practice nurses, due to their low numbers. 
Shift work was defined as work performed outside of ‘office’ hours and included evening shifts, 
rotating shifts and night shifts or a combination of these. Work contract was classified as working 
full-time or part-time (including casual/ pool contracts).   
 
Cancer screening: the stem question used to assess engagement in cancer screening asked ‘When 
did you last have a routine screening test?’ Each item was answered by indicating if respondents had 
a routine Pap test, a mammogram, prostate test, a bowel cancer check and/or skin check in the past 
two years, more than two years ago, never, or the question was not applicable to them. Those who 
did not reply to these questions were excluded from this sub-study.  
 
Statistical analyses 
Data were entered into SPSS version 22.0® for cleaning and analysis. In calculating screening rates, 





excluded them: and N=277, N=10, N=31, N=92 and N=3 respondents indicated that cervical, breast, 
bowel, skin and prostate screening was not applicable for them, respectively. Differences in 
screening rates within the previous two years were analysed according to demographic (age and 
gender), geographical area, and work-related variables using chi-square tests. Chi-square value, 
degrees of freedom and p value are presented (Table 1). Both univariate and multivariate logistic 
regression model analyses were used to assess the associations between cancer screening, 
demographic and work-related characteristics. Assumptions of the models were tested and met; a 
level of significance of 5% was accepted. Wald test value (z), Odds Ratio (OR), P value and 95% 
Confidence Interval (CI) were used to present the results.   
 
RESULTS 
Cervical screening (Pap test) 
Table 1 shows the uptake of age-appropriate cancer screening by NSW nurses and midwives 
compared to the Australian population. Overall, nurses and midwives showed greater adherence to 
cervical screening recommendations than the Australian general population across age groups.  
Of the total 5,041 respondents, 4,355 female nurses and midwives responded to the question on 
cervical screening. Only 3.8% (N=164) had never had a Pap test. Of those aged 18 to 69 years, 72.6% 
(N=2,688) reported having a Pap test within the previous two years. Differences in screening rates 
within the previous two years were analysed according to age and gender, residential and workplace 
geographical area, work role, contract and hours. Significant differences by age were found amongst 
sub-group members, with screening more likely to have occurred within the last two years amongst 
those older (X2(df9)=37.5, p<0.001), for those working part time and casual hours (X2(df1)=15.5, 






Breast screening mammography 
A total of 4,325 female nurses and midwives responded to the breast screening questions. Overall, 
31.8% (N=1,376) had had a mammography; 14.9% (N=617) had, at some point, received an 
abnormal result. A sub-sample of 2,161 female nurses and midwives aged 50-69 years responded to 
the breast screening questions, of whom 76.9% (N=1,654) had undergone routine mammography 
within the previous two years. Differences in screening rates within the previous two years were 
analysed according to age and gender, residential and workplace geographical area, work role, 
contract and hours. Screening uptake was significantly higher for older nurses and midwives 
(X2(df3)=20.1, p<0.001), for those working office hours rather than shifts (X2(df1)=11.2, p=0.001), on 
a part time rather than full time basis (X2(1)=5.62, p=0.02), and in primary, community or outpatient 
settings (X2(df3)=10.9, p=0.01) (Table 1).  
  
Bowel screening  
A total of 4,648 male and female nurses and midwives responded to the bowel screening questions. 
Overall, 48.1% (N=2,234) had never undergone a bowel cancer screening test; 4.3% (N=184) had, at 
some point, received an abnormal result. A sub-sample of 2,257 nurses and midwives aged 50-69 
years replied to these questions, of whom 53.2% had undergone a bowel cancer screening test in 
the previous two years. Differences in screening rates within the previous two years were analysed 
according to age and gender, residential and workplace geographical area, work role, contract and 
hours. Screening uptake was significantly lower at age 50-54 years and progressively increased to 
peak at 65-69 years (X2(df3)=43.3,p<0.001), and greater amongst part-time rather than full time 
employees (X2(df1)=11.4, p=0.001) (Table 1). 
 





In total, 4,711 (93.5%) of survey respondents replied to the skin screening questions. Overall, 42.2% 
(N=1,945) respondents had undertaken some form of skin cancer screening in the previous two 
years; 18.5% (N=931) had, at some point, received an abnormal result. Differences in screening rates 
within the previous two years were analysed according to age and gender, residential and workplace 
geographical area, work role, contract and hours. Screening rates increased significantly with age 
(X2(df9)=202.9, p<0.001). Screening occurred significantly less often amongst those working in 
hospitals compared to all other settings (X2(df3)=21.9, p<0.001), amongst full-time compared to 
part-time workers (X2(df1)=31.0, p<0.001), and those working shifts rather than day workers 
(X2(df1)=9.32, p=0.002). Those working in AIN rather than all other roles were significantly less likely 
to have undertaken skin cancer screening (X2(df3)=13.0, p=0.005) (Table 1).  
 
Prostate screening 
Of 458 male respondents, 444 responded to the prostate screening question. In total, 44.1% (N=196) 
of all male respondents reported undergoing prostate screening at some time; 49.3% (N= 219) had 
never undergone prostate screening; 5.7% (N=14) had experienced an abnormal result. Differences 
in screening rates within the previous two years were analysed according to age, residential and 
workplace geographical area, work role, contract and hours. Of 170 male respondents aged 50-70 
years who responded to the prostate screening question, overall 76.5% (N=130) had undergone 
prostate screening at some time, and 51.2% (N=87) within the past two years. Screening rates 
increased significantly with increasing age (X2(df2)=8.15, p=0.02) (Table 1). 
 
Logistic regression models  
There were differences in cancer screening uptake across workplace settings and locations, age 





potential predictor factors were assessed using logistic regression models. Both univariate and 
multivariate model analyses were conducted and results are presented in Table 2.  
For cervical screening of females aged 18-69 years, the final multivariate regression model revealed 
strong associations between uptake and work setting and contract status. Compared with nurses 
and midwives who worked in aged care, rehabilitation and disability settings, those who worked in 
hospitals (z=2.72, p=0.007, 95% CI: 0.09; 1.69), primary care, community, out-patient (z=3.14, 
p=0.002, 95%CI: 1.17; 1.99) and other settings were significantly more likely (z=2.40, p=0.02, 95% CI: 
1.08; 2.10) to undertake cervical screening (OR=1.35, 1.53 and 1.50 higher, respectively). Compared 
with full-time workers, those who worked part-time and casual hours were also more likely to have 
been screened (OR=1.38, z=4.17, p<0.001; 95% CI: 1.18; 1.60) (Table 2). 
For females aged 50-69, significant associations were found between breast screening and age 
(z=4.01, p<0.001, 95% CI: 1.03; 1.08), contract status (z=2.70, p=0.007, 95% CI: 1.08; 1.65), and 
roster status (z=-3.74, p<0.001, 95% CI: 0.54; 0.83). Older nurses and midwives were 5% more likely 
to have undertaken breast screening. Compared with full-time workers, part-time and casual nurses 
and midwives were 34% more likely to have been screened, whilst shift workers were 33% less likely 
to have been screened than day workers (Table 3). 
For bowel screening, there were significant associations with both contract (z=3.74, p<0.001, 95% CI: 
1.17; 1.66) and roster status (z=-2.57, p=0.01, 95% CI: 0.67; 0.95) for males and females aged 50-69 
years. Part-time and casual workers were 39% more likely to have been screened than full –time 
nurses and midwives, with shift workers 20% less likely to have been screened than day workers 
(Table 4). 
For skin cancer screening, there were significant associations with age, work roles and roster status 
for both males and females aged 20-69 years. Older nurses and midwives were 4% more likely to 
undertake skin screening (z=12.8, p<0.001, 95% CI: 1.03; 1.05). Compared with AINs, those working 





2.32) and advanced practice nurses and midwives (z=1.78, p=0.08, 95% CI: 0.97; 2.12) were all more 
likely to undertake skin screening (OR=1.28, 1.62 and 1.43, respectively). Compared with full-time 
workers, part-time nurses and midwives were 35% more likely to undertake skin screening (z=4.30, 
p<0.001, 95% CI: 1.18; 1.54) (Table 5). 
No significant differences were found in relation to prostate screening.  
DISCUSSION 
A positive picture emerged from this study of nurses’ and midwives’ cancer screening behaviours, 
particularly in regard to cervical and breast screening, in which, 72.6% and 76.9%, respectively, were 
adherent to recommended screening guidelines. Furthermore, approximately half of the age-eligible 
participants were up-to-date with biennial bowel screening. With a sample approximating to the 
Australian nursing and midwifery workforce (Perry et al. 2016), comparisons of results to those of 
the Australian population showed nurses with higher uptake rates of cervical (at 72.6% compared to 
58.2%), breast (at 76.9% compared to 54.6%) and bowel screening (at 53.2% compared to 37.3%) 
within the recommended two-year period. Uptake of organised screening, particularly bowel 
screening, could still be improved in this Australian nursing workforce, as high rates of participation 
are associated with mortality reduction among appropriate age groups.   
Skin cancer screening (clinical or self-examination) was conducted in the past two years by only 
42.2% of participants. This also may be at higher rates than Australian general populations, reported 
to range from 26% to 48% for annual/regular skin self-examination (Girgis et al. 1991, Aitken et al. 
2004) and 11% to 18% for annual clinical skin examination (Girgis et al. 1991, Janda et al. 2004). 
Current Medicare (2015) estimates of approximately 20% of Australian men aged 45-74 years having 
a PSA test every year (778,500 PSA tests were performed in 2012) (AIHW 2013b) may not be 
dramatically different to findings of 51.2% of respondent male nurses undergoing prostate screening 





criteria, some potential differences in test methods and some uncertainty about the risk status of 
those replying that survey questions were ‘not applicable’.   
Overall, findings show the majority of age-eligible nurses and midwives in this study are relatively 
more adherent to screening recommendations than the general population, indicating proactive 
engagement in protecting their health. It is heartening that geographical location was not a 
deterrent to screening participation, with no significant effect observed for regional and rural 
residence. In the Australian general population, lower participation in cancer screening is usually 
found in remote communities compared to regional or metropolitan areas (AIHW 2015, 2016 a,b). 
Lower participation is usually linked with factors such as low socio-economic status, low health 
literacy and low patient-provider communication (Siahpush and Singh 2002, Martini et al. 2011, 
Ward et al. 2011, McLachlan et al. 2012).  Fear, embarrassment and disgust of the screening test are 
also well-known barriers (Bukowska-Durawa and Luszczynska, 2014, Chambers et al. 2016, Chorley 
et al. 2016).  
Working nurses and midwives might be anticipated to be less affected by socio-economic status; 
should have good health literacy and communication with healthcare providers, and may be more 
immune to fear and embarrassment of the test, due to the nature of their roles.  This is perhaps 
what is reflected by similar screening rates for these participants across all areas and age groups.  
Nurses’ uptakes of screening were in line with studies showing that internationally, nursing 
populations in ‘Western’ countries prioritise screening. Eighty-six percent of 1021 health workers 
(n=490 nurses) in the United Kingdom (UK) had a Pap test in the previous 5 years (Jinks et al. 2003) 
and in Canada, nurses (N=1,769) were more likely to ever have had a Pap test or mammography 
compared with other occupations (Pap test 97.4% vs 91.0%, mammography 49.8% vs 36.0%) (Ratner 
and Sawatzky 2009).  Lower cervical screening rates in Asian nursing workforces, of 42.2% in 
Singapore (Tay et al. 2015), 53.8% in Korea (Ju et al. 2003) and 48.9% in Taiwan, may reflect more 





many without organised cancer screening programs, screening is extremely low in nurse and general 
populations (Odusanya et al. 2001, Mutyaba et al. 2006, Canbulat et al. 2008, Akhigbe et al. 2009). 
Internationally, there are few data concerning nursing workforce uptake of bowel, prostate and skin 
cancer screening. Extremely low FOBT screening (1.2%) and relatively high PSA testing (65.7%) were 
reported in Brazilian physicians, nurses and assistants (N=333) (Gonçalves-Silva et al. 2010). In the 
United States (US), shift workers from a variety of professions including health care (N=9,009), had 
high participation in breast and cervical screening, but only about half were adherent to bowel 
screening (Tsai et al. 2014). This is similar to screening rates among nurse shift workers in this study, 
with relatively high cervical and breast screening and lower bowel screening (72.0%, 73.6% and 
50.2%). However, direct comparisons are limited by the difference in recommended screening 
intervals for cervical, breast and bowel screening between the two countries.   
FOBT testing is recommended biennially in most countries, although recommended annually in the 
US. Australia is generally more conservative with its biennial cervical screening recommendation, as 
most other countries (including the US and UK) recommend Pap smears triennially. Breast screening 
recommendations vary between 2 to 3 year intervals worldwide. Australia is in line with other 
countries for the age of commencement of bowel and breast screening at 50 years but cervical 
screening commencement is at 18 years in Australia, compared with 20-25 years in many countries 
(Public Health England 2015a,b, American Cancer Society 2016a,b, USPTF 2012, Linos et al. 2000).  
No country has implemented a population-based prostate or skin screening program, except for the 
German national clinical skin screening program (Trautmann et al. 2016). Routine screening by full 
skin clinical examination is not recommended in most countries, including those with high incidences 
of melanoma (New Zealand Cancer Society 2010, Cancer Research UK 2016, Norwegian Cancer 
Society 2016, USPTF 2016).  Skin self-examination and opportunistic clinical examination of unusual 
skin changes is more widely recommended (NZ Cancer Council 2010, Cancer Council Australia 2014, 





recommended in most countries, although this is very contentious and conflicting advice is often 
given (USPTF, 2016, American Cancer Society 2016c). 
The balance of benefit is widely accepted for bowel and cervical cancer screening programs. The 
decline in cervical cancer incidence by 33%, and mortality by 36%, in the years following the 
introduction of the cervical screening program are largely attributed to routine screening and 
improvements in treatment (Canfell et al. 2006). Randomised trials of FOBT screening have reported 
reductions of bowel cancer mortality of 33% (annual screening) and 16% (biennial screening) 
(Mandel et al. 1993, Hardcastle et al. 1996). Furthermore, despite controversy and debate, the 
recent IARC review panel concluded that mammography screening is effective in reducing breast 
cancer mortality for women aged 50-74 years based on available evidence, and this reduction 
outweighs the adverse effects for women (Lauby-Secretan et al. 2015). Health benefits could 
therefore follow if nurses’ and midwives’ screening behaviours were more aligned to recommended 
practice.   
Although half of the male nurses had undergone prostate screening in the past two years, the 
benefits of PSA testing are uncertain and was not supported by leading Australian cancer control 
agencies (at the time they were screened). Screening behaviour may have reflected uncertainty with 
recommended guidelines, given the misrepresentations and encouragement for screening in the 
media and conflicting advice given by urologists (MacKenzie et al. 2007).  With the development of 
new Australian guidelines recommending individual choice based on informed consent (and biennial 
screening if consent is given), nurses may be offered more support in choosing if PSA screening is 
appropriate for them.   
In this study, nurses’ uptake of bowel and skin screening in particular still offers considerable scope 
for improvement. Characteristics linked to screening uptake indicate where future strategies may be 
directed. Age was an important determinant of higher participation in breast and skin cancer 





a significant barrier to screening access, and there were clear trends of poorer uptake by those 
working shifts, many of which entail night work. This aligned to US data, where alternating shift 
workers (evening, night, rotating) were also less adherent to cancer screening compared with 
daytime workers (Tsai et al. 2014).   
As the nursing workforce may be at heightened risk for some cancers, and the workforce is ageing, 
efforts to maintain a sustainable workforce will be supported by effective primary prevention and 
early detection strategies. Workplace strategies should support adequate diet and exercise and 
other healthy behaviours; the detection of pre-cancers and cancers at an early curable stage; and 
limit exposure to carcinogens. Research shows that health facilities can be unhealthy places to work 
and there are a number of obstacles to the maintenance of a healthy lifestyle and the prevention of 
ill health, which can be minimised (Wong et al. 2010, Han et al. 2011). 
Nurses and midwives are recognised as role models for the public because of their status as health 
professionals and their health literacy.  However, there is little acknowledgement that for many, 
engaging in preventive health behaviours may be difficult as they juggle competing demands of 
domestic responsibilities with inflexible work schedules, long or unsocial hours and emotionally 
challenging work.  Full time working posed a significant barrier to screening access, and there were 
clear trends of poorer uptake by those working shifts. Shift workers may be less likely to engage in 
cancer screening because of difficulty accommodating healthy behaviours into shift patterns and 
balancing work and family commitments, including around alternate shifts (Tsai et al 2015). Lack of 
time and fatigue have also been reported as barriers to engaging in healthy behaviours (Phiri et al. 
2014) and health promotion activities at work may be more frequent during day time hours (Tsai et 
al. 2014). 
Important opportunities for health promotion may be achieved by integrating cancer prevention and 
screening into worksite health promotion programs, and organisational support can improve the 





call for flexible hours for shift workers so that preventive health behaviours can be accommodated 
(Nelson et al. 2014). Worksite-based screening and targeting shift-workers might be some ways to 
overcome access issues and has support among nurses (Jinks et al. 2003, Tsai et al. 2014, Nahmias et 
al. 2016). These strategies have had some success in increasing knowledge and/or screening uptake 
among nurses and workers in other occupations (Girgis et al. 1994, Allen et al. 2001, Jensen et al. 
2014, Uslu et al. 2016). Awareness and education programs should consider a focus on AIN staff, 
more junior nurses, those with lesser health literacy and for skin cancers for hospital workers in 
particular. As with all eligible populations, informed decisions should be promoted so that there is 
increased understanding of both the benefits and the risks of screening, especially for PSA screening 
where the benefits are less certain. 
Study limitations:  
Study limitations include that screening rates might be over or under-estimated because the 
questionnaire did not specifically ask whether testing was done for screening, diagnostic or 
monitoring reasons, although participants were asked about routine screening practices. Some ‘not 
applicable’ responses may have been inappropriate and have reflected ignorance of recommended 
practice. Over or under estimated recall may have occurred when determining biennial screening 
rates, particularly because the National Bowel Cancer Screening Program invited at five-yearly 
intervals at the time nurses screening behaviours were determined. The questionnaire did not ask 
which particular prostate, bowel or skin cancer test participants had, and although PSA, FOBT and 
skin self-examination are the most common, several test options are available. Caution should be 
exercised with direct comparisons with general population screening rates where the test is known. 
Finally, data are self-reported and therefore may be subject to self-report response bias. 
CONCLUSION 
This was the first Australian study where the personal screening behaviours of nurses and midwives 





nurses, compared with the general public, is good news for the health of nurses and midwives and 
the community that relies on their care. Study findings suggest this ageing workforce is making 
protective choices which will impact their future risk of illness and premature departure from the 
workforce. However, findings also indicate avenues to further improve participation rates, 
particularly for skin and bowel cancer screening, and to ensure those thinking of undergoing 
screening fully understand its relative risks and benefits. 
The study provides information of use to managers, policy-makers and staff in the development of 
targeted education and screening interventions capable of delivery in the workplace. With growing 
alarm over increasing rates of non-communicable disease and the effect on the health and 
productivity of the workforce, this study suggests practical ways forward to protect the health of 
workers at the core of the health system. In light of global nursing shortages and the ageing of the 
workforce, strategies that focus on preventing non-communicable diseases, such as cancer, offer 
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 Table 1. Uptake of age-appropriate cancer screening by New South Wales nurses and midwives* compared to the Australian population 
 
Cervical screening                                      
Female nurses/midwives 18-69 
years (biennial) 
Breast screening                               
Female nurses/midwives 50-69 
years (biennial) 
Bowel screening                                      
Female & male nurses/midwives 50-
69 years (biennial) 
Skin screening                                      
Female & male nurses/midwives 
20-69 years (biennial) 
Prostate screening                            





































Age group   37.5 
(p<0.001) 
   20.1 
(p<0.001) 
  43.3 
(p<0.001) 
  202.9 
(p<0.001) 
   8.15 
(p=0.02) 
 
20-24 60.0%  42.7%       28.2%      
25-29 68.3%  52.0%       23.5%      
30-34 72.6%  58.1%       27.6%      
35-39 68.0%  61.0%       27.5%      
40-44 77.6%  62.6%       32.1%      
45-49 76.7%  64.5%       41.8%      
50-54 75.6%  64.0% 70.9%  48.9% 48.2%  28.6% 45.4%   40.6%   
55-59 73.2%  61.9% 79.9%  55.0% 54.7%  36.8% 51.4%   61.8%   
60-64 68.3%  60.4% 80.4%  59.9% 71.0%  43.9% 62.3%   66.7%   
65-69 60.0%  52.7% 77.9%  58.5% 64.0%  44.2% 57.3%      
% Total 18-69 
years 
72.6%  58.2%       42.2%  11%-48%    
% Total 50-69 
years 
   76.9%  54.6% 53.2%  37.3%₃    51.2%  20%₅ 
Area  5.01 
(p=0.08) 
  0.15 
(p=0.93) 
  3.97 
(p=0.14) 
  1.61 
(p=0.45) 
  0.54 
(p=0.76) 
 
Major cities 73.7%  58.1% 76.7%  53.1% 54.8%  36.6% 41.5%   54.1%   
Inner regional 71.7%  59.7% 76.6%  57.4% 51.4%  40.0% 43.6%   48.3%   
Outer regional/ 
remote 
69.6%  57.5% 78.0%  59.1% 48.1%  37.5% 43.0%   55.6%   
Gender        0.23 
(p=0.64) 
  0.14 
(p=0.71) 
    
Female          53.2%  40.0% 42.3%       





  10.9 
(p=0.01) 
  4.90 
(p=0.18) 
  21.9 
(p<0.001) 
  1.01 
(p=0.80) 
 












75.2%   81.2%   57.1%   46.5%   50.0%   
Other 73.3%   79.2%   54.1%   49.2%   58.6%   
Shifts  0.81 
(p=0.37) 
  11.2 
(p=0.001) 
  3.28 
(p=0.07) 
  9.32 
(p=0.002) 
  0.03 
(p=0.86) 
 
Day work 73.3%   79.7%   54.9%   44.6%   52.7%   
Shift work  72.0%   73.6%   50.2%   39.9%   51.4%   
Work contract  15.5 
(p<0.001) 
  5.62 
(p=0.02) 
  11.4 
(p=0.001) 
  31.0 
(p<0.001) 





75.6%   79.0%    56.7%   46.8%   50.0%   
Full time  69.8%   74.7% 
 
 49.6%   38.3%   52.9%   
Role  8.48 
(p=0.03) 
  4.76 
(p=0.19) 
  2.42 
(p=0.49) 
  13.0 
(p=0.005) 
  3.63 
(p=0.30) 
 
**AIN 64.9%   70.6%   46.6%   35.6%   50.0%   
Foundational 72.9%   77.2%   53.6%   41.2%   46.7%   
Domain specific 71.5%   75.4%   51.6%   47.6%   63.0%   
Advanced 
practice 
77.2%   81.7%   55.3%   43.8%   45.0%   
* Of the total 5,446 responses, 405 (7.4%) were excluded due to missing data or because respondents were non-practicing, leaving 5,041 respondents. Chi-square (X2) tests were used to assess the differences in 
screening rates within the previous two years according to age (and gender), residential and workplace geographical area, shift, work contract and work roles.   
** Assistant in Nursing 
1. Age standardised rate - the number of Australian women screened in 2012–2013 as a percentage of the Australian Bureau of Statistics (ABS) estimated resident population for women aged 20–69, 
adjusted to include only women with an intact cervix using age-specific hysterectomy fractions derived from the AIHW National Hospitals Morbidity Database, age-standardised to the Australian 
population at 30 June 2001 (AIHW, 2016a) 
2. Age-standardised (AS) rates are the number of Australian women screened as a percentage of the eligible female population calculated as the average of the 2012 and 2013 ABS estimated resident 
population and age standardised to the Australian population at 30 June 2001. Period covers Jan 2012- Dec 2013 (AIWH, 2015) 
3.  Of the Australian population aged 50-65 years invited in the 2 yearly 2013–2014 period, 37.3% participated in the National Bowel Cancer Screening Program – using the Faecal Occult Blood Test (AIHW, 
2016b). The participation indicator reports a 2-year period but at the time of this study the eligible population (50- 65 years) were invited 5 yearly (2 yearly screening is currently being implemented) 
4. Australian skin screening annual/regular prevalence among selected populations is reported to range from 26% to 48% for skin self-examination (Girgis et al. 1991, Aitken et al. 2004) and 11% to 18% for 
clinical skin examination (Girgis et al. 1991, Janda et al. 2004).  
5. Analysis of Medicare Benefits Schedule (MBS) records suggest that each year about 20% of men aged between 45 and 74 have a PSA test, presumably for the purpose of early diagnosis of prostate cancer. 







Table 2. Logistic regression modelling of significant factors for uptake of age-appropriate cervical cancer screening by NSW nurses and midwives 
Factor Univariate Model Final Multivariate Model* 
 OR  (95% CI) Wald test values (z) P value OR (95% CI) Wald test values (z) P value  
Age  1.01 (0.99; 1.01) 1.16 0.34    
Area       
Metro (Ref) 1      
Inner regional  0.91 (0.77; 1.07) -1.19 0.24    
Outer/remoter regional  0.75 (0.57; 0.98) -1.92 0.04    
Work setting        
Aged care /rehab / 
disability (Ref) 
1   1   
Hospital 1.26 (1.01; 1.55) 2.07 0.04 1.35 (0.09; 1.69) 2.72 0.007 
Primary care/ community/ 
outpatient 
1.43 (1.10; 1.85) 2.65 0.007 1.53 (1.17; 1.99) 3.14 0.002 
Others 1.29 (0.94; 1.77) 1.84 0.11 1.50 (1.08; 2.10) 2.40 0.016 
Contract       
Full-time (Ref ) 1   1   
Part-time/casual/pool 1.34 (1.16; 1.55) 3.75 <0.001 1.38 (1.18; 1.60) 4.17 <0.001 
Work role       
AIN (Ref) 1      
Foundational  1.45 (1.05; 2.02) 2.13 0.03    
Domain specific 1.36 (0.94; 1.96) 1.51 0.10    
Advanced practice  1.86 (1.20; 2.80) 2.88 0.01    
Roster       
Day work (Ref) 1      
Shift work 0.94 (0.81; 1.08) -0.95 0.37    






Table 3. Logistic regression modelling of significant factors for uptake of age-appropriate breast cancer screening by NSW nurses and midwives 
Factor Univariate Model Final Multivariate Model* 
 OR  (95% CI) Wald test value (z) P value OR (95% CI) Wald test value (z) P value  
Age  1.06 (1.03; 1.08) 3.91 <0.001 1.05 (1.03; 1.08) 4.01 <0.001 
Area       
Metro (Ref) 1      
Inner regional  0.99 (0.79; 1.24) 0.02 0.93    
Outer/remoter regional  1.07 (0.73; 1.58) 0.45 0.72    
Work setting        
Aged care/rehab / 
disability (Ref) 
1      
Hospital 1.03 (0.78; 1.37) 0.40 0.81    
Primary care/ community/ 
outpatient 
1.55 (1.11; 2.17) 2.61 0.01    
Others 1.31 (0.88; 1.97) 1.43 0.18    
Contract       
Full-time (Ref ) 1   1   
Part-time/casual/pool 1.28 (1.04; 1.56) 2.33 0.02 1.34 (1.08; 1.65) 2.70 0.007 
Work role       
AIN (Ref) 1      
Foundational  1.41 (0.87; 2.28) 1.51 0.16    
Domain specific 1.28 (0.76; 2.15) 1.03 0.35    
Advanced practice  1.86 (1.02; 3.38) 2.12 0.04    
Roster       
Day work (Ref) 1   1   
Shift work  0.71 (0.58; 0.87) -3.29 0.001 0.67 (0.54; 0.83) -3.74 <0.001 








Table 4. Logistic regression modelling of significant factors for uptake of age-appropriate bowel cancer screening by NSW nurses and midwives   
Factor Univariate Model Final Multivariate Model* 
 OR  (95% CI) Wald test value (z) P-value OR (95% CI) Wald test value (z) P value  
Age  1.02 (1.00; 1.04) 1.99 0.03    
Gender       
Female (Ref) 1      
Male 0.92 (0.67; 1.28) -0.54 0.64    
Area       
Metro (Ref) 1      
Inner regional  0.87 (0.73; 1.05) -1.56 0.14    
Outer/remoter regional  0.77 (0.55; 1.06) -1.65 0.11    
Work setting        
Aged care/rehab / 
disability (Ref) 
1      
Hospital 0.93 (0.73; 1.18) -0.62 0.55    
Primary care/ community/ 
outpatient 
1.18 (0.89; 1.55) 1.03 0.25    
Others 1.04 (0.75; 1.45) 0.26 0.81    
Contract       
Full-time (Ref ) 1   1   
Part-time/casual/pool 1.33 (1.13; 1.58) 3.28 0.001 1.39 (1.17; 1.66) 3.74 <0.001 
Work role       
AIN (Ref) 1      
Foundational  1.33 (0.86; 2.04) 1.27 0.20    
Domain specific 1.22 (0.77; 1.93) 0.87 0.40    
Advanced practice  1.42 (0.85; 2.35) 1.32 0.18    
Roster       
Day work (Ref) 1   1   
Shift work  0.86 (0.73; 1.01) -1.82 0.07 0.80 (0.67; 0.95) -2.57 0.01 






Table 5. Logistic regression modelling of significant factors for uptake of skin cancer screening by NSW nurses and midwives 
Factor Univariate Model Final Multivariate Model* 
 OR  (95% CI) P-value OR (95% CI) P value  
Age  1.04 (1.04; 1.05) <0.001 1.04 (1.03; 1.05)  <0.001 
Gender     
Female (Ref) 1    
Male 0.96 (0.78; 1.19) 0.71   
Area     
Metro (Ref) 1    
Inner regional  1.09 (0.95; 1.25) 0.22   
Outer/remoter regional  1.06 (0.83; 1.37) 0.64   
Work setting      
Aged care/rehab / 
disability (Ref) 
1    
Hospital 0.84 (0.69; 1.01) 0.06   
Primary care/ community/ 
outpatient 
1.12 (0.89; 1.39) 0.33   
Others 1.25 (0.96; 1.62) 0.10   
Contract     
Full-time (Ref ) 1  1  
Part-time/casual/pool 1.42 (1.25; 1.60) <0.001 1.35 (1.18; 1.54) <0.001 
Work role     
AIN (Ref) 1  1  
Foundational  1.27 (0.93; 1.74) 0.14 1.28 (0.92; 1.77) 0.14 
Domain specific 1.65 (1.17; 2.31) 0.004 1.62 (1.13; 2.32) 0.009 
Advanced practice  1.41 (0.97; 2.05) 0.07 1.43 (0.97; 2.12) 0.08 
 
Roster 
    
Day work (Ref) 1    
Shift work  0.83 (0.73; 0.93) 0.002   
 
